Method of treating female sexual dysfunction with a PDE1 inhibitor
US9006258B2 · kind B2 · utility
25Cited by
33References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2007 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Mar 1, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a new use for compounds that inhibit phosphodiesterase 1 (PDE1), e.g., that inhibit PDE1-mediated suppression of the dopamine D1 receptor and/or progesterone signaling pathways, including, e.g., methods of treatment or prophylaxis for conditions which may be ameliorated by enhancing the progesterone signaling response, particularly female sexual dysfunction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.